|
|
TTD Drug ID:
DCL000145
Drug
Information |
Name | KU-0059436 | Synonyms | 4-[(3-{[4-Cyclopropylcarbonyl)piperazin-4-yl]carbonyl}-4-fluorophenyl)methyl]phtalazin-1(2H)-one; 937799-91-2; AZD2281; KU-0059436; AKOS005145764; Olaparib, KU-0059436, AZD2281, KU0059436, AZD2281; S1060_Selleck; Olaparib; AZD-2281; AZD 2281; EC-000.2324; CHEMBL521686; EN002690; KU-59436; 4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one; 763113-22-0; FT-0083489; Acylpiperazine analogue, 47 | Company | AstraZeneca | Indication | Gastric Cancer; Breast Cancer; Ovarian Cancer [ICD9: 140-229, 151, 174, 175, 183 ICD10: C00-C96, C16, C50, C56] | Phase II | Neoplasm Metastasis; Solid Tumors [ICD9: 140-199, 140-239, 210-229 ICD10: C00-C75, C00-C96, C7A, C7B, D10-D36, D3A] | Phase I | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-2 1)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16 H,6-7,9-12,14H2,(H,27,30) | InChIKey | FDLYAMZZIXQODN-UHFFFAOYSA-N | Canonical SMILES | C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F | Therapeutic Class | Antineoplastic Agents | CAS Number | CAS 937799-91-2 | PubChem Compound ID | CID 23725625. | PubChem Substance ID | SID 47209066. | ClinicalTrials.gov | NCT00633269; | NCT01063517; | Target | Poly [ADP-ribose] polymerase 1 |  | Inhibitor | [1][2][3] | Ref 1 | High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs. Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17079-84. Epub 2008 Oct 29. To Reference | Ref 2 | Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1188-97.Replication-dependent radiosensitization of human glioma cells by inhibition of poly(ADP-Ribose) polymerase: mechanisms and therapeutic potential. To Reference | Ref 3 | J Med Chem. 2008 Oct 23;51(20):6581-91. Epub 2008 Sep 19.4-[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: a novel bioavailable inhibitor of poly(ADP-ribose) polymerase-1. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|